|
|
Article: VERONA PHARMA PLC - Half-yearly Report.
- Article from:
- PR Newswire UK Disclose
- Article date:
- September 4, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
4 September 2009
Verona Pharma plc
("Verona Pharma" or the "Company")
INTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2009
The Board of Verona Pharma, the drug discovery company, is pleased to announce
its Interim Results for the six months to 30 June 2009.
Highlights
* Verona Pharma's primary drug project, RPL554, safely passed the first two
stages of a three stage Phase I/IIa clinical trial on 20 May 2009
* RPL554 is now being evaluated for therapeutic effectiveness and safety
following aerosol administration to the ...
Related newspaper, magazine, and journal articles:
|
|
Article: VERONA PHARMA PLC - Proposed Placing and ...
PR Newswire UK Disclose;
December 17, 2007 ;
700+ words
...VERONA PHARMA PLC ( Verona Pharma or the Company ... Professor Clive Page, Chairman, Verona Pharma plc: 07971 504 931 David Youngman ... 2666 Background information About Verona Pharma plc Verona Pharma is an AIM-quoted ...
|
|